Urine Biopsy—Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer

With recent advancements in a non-invasive approach to cancer diagnosis and surveillance, the term “liquid biopsy” has gained traction but is currently limited by technological challenges in identifying and isolating circulating tumor cells (CTCs), proteins, cell-free DNA (cfDNA), or other nucleic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Satyal, Uttam, Srivastava, Abhishek, Abbosh, Philip H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877686/
https://www.ncbi.nlm.nih.gov/pubmed/31803629
http://dx.doi.org/10.3389/fonc.2019.01266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877686/
https://www.ncbi.nlm.nih.gov/pubmed/31803629
http://dx.doi.org/10.3389/fonc.2019.01266

Ejemplares similares